1. Home
  2. KTCC vs SER Comparison

KTCC vs SER Comparison

Compare KTCC & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Key Tronic Corporation

KTCC

Key Tronic Corporation

HOLD

Current Price

$3.03

Market Cap

28.6M

Sector

Technology

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$1.65

Market Cap

29.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTCC
SER
Founded
1969
2017
Country
US
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
29.3M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
KTCC
SER
Price
$3.03
$1.65
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
13.9K
1.3M
Earning Date
04-30-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$467,871,000.00
N/A
Revenue This Year
N/A
$134.46
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.21
$1.63
52 Week High
$3.69
$7.92

Technical Indicators

Market Signals
Indicator
KTCC
SER
Relative Strength Index (RSI) 56.24 32.94
Support Level $2.97 $1.65
Resistance Level $3.25 $2.01
Average True Range (ATR) 0.17 0.36
MACD 0.00 -0.11
Stochastic Oscillator 56.87 0.82

Price Performance

Historical Comparison
KTCC
SER

About KTCC Key Tronic Corporation

Key Tronic Corporation provides electronic manufacturing services, including engineering, materials management, manufacturing and assembly, in-house testing, and distribution to various countries. The company serves diverse industries such as pest control, personal protection, air purification, automotive, medical technology, and utilities inspection equipment. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly. Key Tronic operates manufacturing facilities in the United States, Vietnam, and Mexico, recently expanding with a new facility in Arkansas. Revenue is generated mainly through contract manufacturing and service agreement.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: